Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients

Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients

Background: Allogeneic hematopoietic stem cell transplantation (ASCT) induces acquired immunodeficiency, potentially altering vaccine response. Herein, we aimed to explore the clinical tolerance and the humoral and cellular immune responses following anti-SARS-CoV-2 vaccination in ASCT recipients. M...

Full description

Bibliographic Details
Main Authors: Ahmed Amine Ben Khlil, Imen Zamali, Dorra Belloumi, Mariem Gdoura, Ghassen Kharroubi, Soumaya Marzouki, Rym Dachraoui, Insaf Ben Yaiche, Soumaya Bchiri, Walid Hamdi, Manel Gharbi, Ahlem Ben Hmid, Samar Samoud, Yousr Galai, Lamia Torjmane, Saloua Ladeb, Jihene Bettaieb, Henda Triki, Nour Ben Abdeljelil, Tarek Ben Othman, Melika Ben Ahmed
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Vaccines
Subjects:
COVID-19
vaccines
humoral immunity
cellular immunity
Online Access:https://www.mdpi.com/2076-393X/12/2/174

Similar Items

Similar Items